Articles

Nearly 160 million Americans get insurance through employers, but that does not mean it’s good social policy.

Researchers found the use of dementia specialty care is particularly low for Hispanics and Asians.

Rosalie Liccardo Pacula is a nationally recognized expert in the economics of substance use and addiction, including opioids, cannabis, and alcohol.

Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.

A mix of universal catastrophic coverage and private insurers would be cheaper than Medicare for All, Dana Goldman wrote in MarketWatch.

Experts from the USC-Brookings Schaeffer Initiative for Health Policy answer commonly asked questions about surprise medical bills and how to deal with them at a policy level.

USC-Brookings Schaeffer Initiative experts provide an analysis of a voluntary vendor approach for Medicare to restrain drug spending for Part B drugs.

As a kidney doctor and health policy researcher, I am surprised that President Donald Trump’s initiative to remake kidney treatment has not gotten more attention. We need to keep paying attention because so much is at stake.

USC-Brookings Schaeffer Initiative researchers review the latest proposed legislation from Representative Ruiz on surprise medical billing.

How can lawmakers build on the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009? USC-Brookings Schaeffer Initiative Director Paul Ginsburg shares his thoughts in The New England Journal of Medicine.